Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study

This publication has 34 references indexed in Scilit:

• Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women
  Atherosclerosis, 2013
• Future of High-Density Lipoprotein Infusion Therapies
  Circulation, 2013
• High-Density Lipoproteins
  Circulation Journal, 2013
• Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)
  Journal of Clinical Lipidology, 2012
• Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: A monozygotic twin pair study
  Atherosclerosis, 2011
• Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic Syndrome
  Diabetes Care, 2007
• An ω-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia
  Metabolism, 2004
• AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update
  JACC, 2001
• Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• An optimized method for measuring lecithin: Cholesterol acyltransferase activity, independent of the concentration and quality of the physiological substrate
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981